A61K 31/69
Boron compounds
A61K31/69 (Boron compounds) appears on 935 US grants and 1,805 published applications in this corpus.
Search patents in A61K- Granted patents
- 935
- Published applications
- 1,805
- Assignees
- 752
- Inventors
- 3,466
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 5 |
| 2003 | 3 | 9 |
| 2004 | 6 | 23 |
| 2005 | 8 | 21 |
| 2006 | 6 | 26 |
| 2007 | 7 | 22 |
| 2008 | 5 | 18 |
| 2009 | 3 | 38 |
| 2010 | 17 | 43 |
| 2011 | 13 | 52 |
| 2012 | 17 | 53 |
| 2013 | 34 | 80 |
| 2014 | 55 | 108 |
| 2015 | 63 | 98 |
| 2016 | 64 | 121 |
| 2017 | 67 | 109 |
| 2018 | 77 | 117 |
| 2019 | 72 | 114 |
| 2020 | 84 | 129 |
| 2021 | 64 | 104 |
| 2022 | 49 | 107 |
| 2023 | 53 | 115 |
| 2024 | 48 | 105 |
| 2025 | 48 | 97 |
| 2026 | 35 | 90 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Eye care composition containing l-ergothioneine, and preparation method therefor and use thereof15 Sep 2026US 12,734,154 B2Gene III Biotechnology Co., Ltd.
- Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors1 Sep 2026US 12,721,847 B2Disc Medicine, Inc.
- Borate complexes of chlorogenic acid and uses thereof1 Sep 2026US 12,721,857 B2P.L. Thomas & Co., Inc.
- PH-responsive lipidoid nanoparticles for intracellular mRNA delivery25 Aug 2026US 12,714,690 B2Trustees of Tufts College
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
- Chemical compounds24 Sep 2026US 2026/0285882 A1AN2 Therapeutics, Inc.
Most cited
By later US patents
- Combinations and modes of administration of therapeutic agents and combination therapy131US 8,034,375 B2Abraxis BioScience, LLC · 2011
- Boron-containing small molecules120US 7,582,621 B2Anacor Pharmaceuticals, Inc. · 2009
- Combinations and modes of administration of therapeutic agents and combination therapy119US 7,758,891 B2Abraxis BioScience, LLC · 2010
- Combinations and modes of administration of therapeutic agents and combination therapy107US 8,268,348 B2Abraxis BioScience, LLC · 2012
- Combinations and modes of administration of therapeutic agents and combination therapy90US 9,101,543 B2Abraxis BioScience, LLC · 2015